G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 115 filers reported holding G1 THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25 | -51.0% | 17,480 | +84.1% | 0.00% | – |
| Q4 2022 | $51 | -100.0% | 9,496 | -51.3% | 0.00% | – |
| Q3 2022 | $243,000 | +556.8% | 19,501 | +424.8% | 0.00% | – |
| Q4 2021 | $37,000 | +117.6% | 3,716 | +374.0% | 0.00% | – |
| Q3 2021 | $17,000 | +6.2% | 784 | +7.1% | 0.00% | – |
| Q2 2021 | $16,000 | -97.1% | 732 | -96.8% | 0.00% | -100.0% |
| Q1 2021 | $554,000 | +16.4% | 23,038 | -13.1% | 0.00% | 0.0% |
| Q4 2020 | $476,000 | +47500.0% | 26,496 | +16884.6% | 0.00% | – |
| Q3 2020 | $1,000 | -85.7% | 156 | -52.0% | 0.00% | – |
| Q2 2020 | $7,000 | +40.0% | 325 | +65.0% | 0.00% | – |
| Q4 2019 | $5,000 | -80.0% | 197 | -82.2% | 0.00% | – |
| Q3 2019 | $25,000 | +1150.0% | 1,107 | +1577.3% | 0.00% | – |
| Q2 2019 | $2,000 | +100.0% | 66 | -34.0% | 0.00% | – |
| Q4 2018 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,423,794 | $34,541,000 | 9.18% |
| Burrage Capital Management LLC | 373,876 | $9,070,000 | 6.35% |
| Birchview Capital, LP | 40,000 | $970,000 | 0.59% |
| 361 CAPITAL LLC | 47,325 | $1,148,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 190,000 | $4,609,000 | 0.50% |
| CHI Advisors LLC | 44,000 | $1,067,000 | 0.42% |
| Bellevue Group AG | 721,925 | $17,514,000 | 0.25% |
| Candriam S.C.A. | 870,423 | $21,117,000 | 0.22% |
| Virtus ETF Advisers LLC | 18,991 | $461,000 | 0.22% |
| HHLR ADVISORS, LTD. | 949,431 | $23,033,000 | 0.21% |